No, the clonidine 0.1 mg/24 hr patch is applied weekly, not daily.
The clonidine transdermal patch is designed for once-weekly application, with each patch delivering medication continuously over a 7-day period 1, 2. This is a critical distinction from daily dosing and represents one of the key advantages of the transdermal formulation.
Dosing Schedule
According to the 2017 ACC/AHA Hypertension Guidelines and FDA labeling:
- Clonidine patch 0.1–0.3 mg/day: Applied once weekly 1
- The patch delivers clonidine at an approximately constant rate for 7 days 2
- Patients should apply a new patch to a fresh skin site at weekly intervals 2
Clinical Pharmacology
The transdermal system is specifically engineered for weekly use:
- Therapeutic plasma clonidine levels are achieved 2-3 days after initial application 2
- The EVA membrane controls drug release to maintain steady delivery for the full 7 days 2
- If removed and not replaced, therapeutic levels persist for about 8 hours, then decline slowly over several days 2
Common Pitfall to Avoid
Do not confuse the "0.1 mg/24 hr" designation with daily application frequency. This nomenclature refers to the delivery rate (0.1 mg per 24-hour period), not the application schedule. The patch continuously releases this amount each day for 7 consecutive days before requiring replacement 2.
Practical Application
- Change the patch every 7 days on the same day each week
- Apply to a hairless area of intact skin on the upper outer arm or chest 2
- Rotate application sites with each new patch to minimize skin irritation
- The once-weekly dosing improves adherence compared to oral formulations, which was particularly beneficial in studies of inner-city populations 3
Important Safety Note
Clonidine is generally reserved as a last-line antihypertensive agent due to significant CNS adverse effects, especially in older adults 1. Never abruptly discontinue clonidine, as this may induce hypertensive crisis; it must be tapered to avoid rebound hypertension 1.